OncoHost Raises $8 Million in Series B Funding Round

June 16, 2025

As AI Dawns in Precision Oncology, 2025 Expected To Be a ‘Turning Point’

June 6, 2025

OncoHost study offers insights into resistance mechanisms in immunotherapy-treated lung cancer

June 2, 2025

OncoHost study offers new insights into resistance mechanisms in immunotherapy-treated lung cancer patients

May 31, 2025

OncoHost Study Offers New Insights into Resistance Mechanisms in Immunotherapy-Treated Lung Cancer Patients

May 30, 2025

OncoHost Developing NeutroFlow Test for Guiding Cancer Therapy Selection

May 20, 2025

OncoHost receives a €2.5 million European grant to advance precision oncology